Manuscripts
Showing 1554 manuscripts.
Associations of Proinflammatory Cytokine Levels With Lipid Profiles, Growth, and Body Composition in HIV-Infected Children Initiating or Changing Antiretroviral Therapy
Citation
Joseph S. Cervia, Caroline J. Chantry, Michael Hughes, Carmelita Alvero, William A. Meyer, Janice Hodge, Peggy R. Borum, John ( Jack ) Moye, Stephen A. Spector. Associations of Proinflammatory Cytokine Levels With Lipid Profiles, Growth, and Body Composition in HIV-Infected Children Initiating or Changing Antiretroviral Therapy. Pediatric Infectious Disease Journal. 2010. 29: 1118-1122. PMID: 20631646Year
2010
Journal
Pediatric Infectious Disease Journal
Study
P1010
Analytical and Biological Considerations in the Measurement of Cell-Associated CCR5 and CXCR4 mRNA and Protein
Citation
Denise Campbell, J. P. Lai, Nancy Tustin, Eric Riedel, Richard Tustin, Jeff Taylor, J. Edward Murray, Steven D. Douglas. Analytical and Biological Considerations in the Measurement of Cell-Associated CCR5 and CXCR4 mRNA and Protein. Clinical and Vaccine Immunology. 2010. 17: 1148-1154. PMID: 20463101Year
2010
Journal
Clinical and Vaccine Immunology
Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral
Citation
Carlum Shiu, Coleen K. Cunningham, Thomas C. Greenough, Petronella Muresan, Victor Sanchez Merino, Vincent J. Carey, Brooks Jackson, Carrie Ziemniak, Lawrence Fox, Marvin Eric Belzer, Stuart C. Ray, Katherine Luzuriaga, Deborah Persaud. Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral. Journal of Virology. 2010. 83: 9731-42.Year
2010
Journal
Journal of Virology
Study
P1059
Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174
Citation
Vicki Stocker, Richard B. Pollard, Kimberly Y. Smith, Lu (Summer) Zheng, Ronald J. Bosch, David M. Margolis, Allan R. Tenorio, Laura A. Napolitano, Michael Switow Saag, Elizabeth Connick, Jody Lawrence, Barry H. Gross, Issac R. Francis, Hernan Valdez, Rui Wang, Norma Muurahainen. Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174. AIDS Research and Human Retroviruses. 2010. 26: 425-432.Year
2010
Journal
AIDS Research and Human Retroviruses
Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS clinical trials group trial A5181
Citation
Bernard J.C. Macatangay, Lu (Summer) Zheng, Charles Rinaldo, Alan Landay, Richard B. Pollard, Savita G. Pahwa, Michael M. Lederman, R. Pat Bucy. Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS clinical trials group trial A5181. Clinical and Vaccine Immunology. 2010. 17: 1452-9. PMID: 20631337Year
2010
Journal
Clinical and Vaccine Immunology
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients.
Citation
Timothy J. Wilkin, Zhaohui Su, Amy Krambrink, Jianmin Long, Wayne Greaves, Robert Gross, Michael Hughes. Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients.. Journal of Acquired Immune Deficiency Syndromes. 2010. 54: 470-6. PMID: 20672447Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein
Citation
Robert T. Schooley, John Spritzler, Hongying Wang, Michael M. Lederman, Diane V. Havlir, Daniel R. Kuritzkes, Richard B. Pollard, Cathy Battaglia, Michael N. Robertson, Devan V. Mehrotra, Danilo R. Casimiro, Kara Cox, Barbara Schock. AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein. Journal of Infectious Diseases. 2010. 202: 705-16. PMID: 20662716Year
2010
Journal
Journal of Infectious Diseases
Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C)
Citation
Kenneth E. Sherman, Janet Andersen, Adeel A. Butt, Triin Umbleja, Beverly L. Alston-Smith, Margaret James Koziel, Marion G. Peters, Mark S. Sulkowski, Z. D. Goodman, Raymond T. Chung. Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C). Journal of Acquired Immune Deficiency Syndromes. 2010. 55: 597-605. PMID: 20921898Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy.
Citation
Jeffrey A. Canter, Gregory K. Robbins, Doug Selph, David B. Clifford, Asha R. Kallianpur, Robert Shafer, Shawn Levy, Deborah G. Murdock, Marylyn D. Ritchie, David W. Haas, Todd Hulgan. African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy.. Journal of Infectious Diseases. 2010. 201: 1703-7. PMID: 20402593Year
2010
Journal
Journal of Infectious Diseases